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Yellowstone National ParkOur understanding of archaeal viruses has been limited by the lack of genetic systems for examining viral
function. We describe the construction of an infectious clone for the archaeal virus Sulfolobus turreted
icosahedral virus (STIV). STIV was isolated from a high temperature (82 °C) acidic (pH 2.2) hot spring in
Yellowstone National Park and replicates in the archaeal model organism Sulfolobus solfataricus (Rice et al.,
2004). While STIV is one of most studied archaeal viruses, little is known about its replication cycle. The
development of an STIV infectious clone allows for directed gene disruptions and detailed genetic analysis of
the virus. The utility of the STIV infectious clone was demonstrated by gene disruption of STIV open reading
frame (ORF) B116 which resulted in crippled virus replication, while disruption of ORFs A197, C381 and B345
was lethal for virus replication.mistry Building, Montana State
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We have a limited understanding of the viruses that infect cellular
hosts belonging to the Archaea. There are ﬁve recognized or proposed
phyla within the domain Archaea, with the majority of viruses having
been isolated from members of the two main phyla, Euryarchaeota
and Crenarchaeota. However, to date only a limited number of
archaeal viruses have been isolated. There are a total of 49
crenarchaeal and euryarchaeal viral genomes sequenced (Ackermann
and Kropinski, 2007; Happonen et al., 2010; Prangishvili et al., 2006;
Redder et al., 2009; Snyder et al., 2003). Few of the open reading
frames in any of these viruses have signiﬁcant similarity to known
genes in the public databases. Seven new viral families have been
created to accommodate this diversity, with more families likely to be
added soon. Infectious clones have only been developed for members
of the Fuselloviridae (Stedman et al., 1999; Jonuscheit et al., 2003;Berkner and Lipps, 2008) and the spherical euryarchaeal viruses
(Porter and Dyall-Smith, 2008).
Sulfolobus solfataricus has emerged as a model organism for the
phylum Crenarchaeota. It is an aerobic heterotrophic thermoacido-
phile (~80 °C and pH 2–4 optimum) that can be easily cultured in the
laboratory. Members of the Sulfolobales have been detected in high
temperature (72–85 °C) acidic (pH 2.0–4.0) hot springs, fumaroles,
and mud pots throughout the world (Brock et al., 1972). The genome
of S. solfataricus strain P2 has been sequenced (She et al., 2001) and a
genetic system has been developed for a close relative of this strain
(Berkner and Lipps, 2008; Contursi et al., 2003; Schelert et al., 2004;
Wagner et al., 2009). Because of the ease of culturing this genus, 15
viruses have been identiﬁed that infect Sulfolobus spp. (Arnold et al.,
2000a,b; Prangishvili et al., 1999; Rice et al., 2004; Schleper et al.,
1992; Stedman et al., 2003; Wiedenheft et al., 2004; Xiang et al.,
2005).
Sulfolobus turreted icosahedral virus (STIV) was originally isolated
from a high temperature (82 °C) acidic (pH 2.2) hot spring in the
Rabbit Creek thermal area of Yellowstone National Park, USA. The
virus was isolated from an enrichment culture of an uncharacterized
Sulfolobus species (Rice et al., 2004). The puriﬁed virus infects the
Italian isolate of S. solfataricus strain P2. The virus particle is a 74 nm
icosahedron (T=31) with turret-like projections extending from its
ﬁve-fold axes of symmetry (Rice et al., 2004; Khayat et al., 2005). The
Fig. 1. Genome map of the full-length clone of STIV. STIV ORFs shown in black and the
pCRII-TOPO-TA vector shown in gray.
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genome encoding 37 open reading frames. Few of the ORFs have any
similarity to known genes in the public databases and thus are
difﬁcult to annotate without structural or functional studies (Khayat
et al., 2005; Larson et al., 2007a,b; Larson et al., 2006; Maaty et al.,
2006; Rice et al., 2004). The replication cycle of STIV is not known, but
comparative genomic and structural analysis has provided insights
into several STIV gene functions. Proteomic analysis of puriﬁed virions
has demonstrated that the virion is comprised of nine viral proteins
(C557, C381, B345, A223, B164, B130, B109, A78, and A55) and two
host proteins (SSO7D and SSO0881) (Maaty et al., 2006). B345 has
been determined to be the major capsid protein (MCP) (Rice et al.,
2004; Khayat et al., 2005), and its structural analysis has provided
evolutionary insights into the relationship between icosahedral
viruses from all three domains of life (Khayat et al., 2005). B164 has
been shown by homology modeling to likely be a viral ATPase (Maaty
et al., 2006). The X-ray crystal structures of three additional STIV
proteins, F93, B116 and A197, have been determined. F93 is a winged-
helix DNA-binding protein that is a putative transcriptional regulator
(Larson et al., 2007a). B116 is a novel DNA binding protein that has
been shown to bind DNA in a non-speciﬁc manner (Larson et al.,
2007b). A197 is a putative glycosyltransferase (Larson et al., 2006).
While STIV is one of the better understood viruses infecting a
crenarchaeal host, much remains to be examined. The ability to
understand the replication cycle of this virus, the details of its
interactions with its host, and the function of its gene products would
be greatly facilitated by the development of an infectious clone that
allows for the directed manipulation of the STIV genome. There is
currently only one other crenarchaeal virus for which there is an
infectious clone, Sulfolobus spindle-shaped virus (SSV) (Stedman
et al., 1999). This paper describes the development of an infectious
STIV clone and its utility for probing viral gene function.
Results
Construction of the full-length STIV/TA clone and demonstration of
infectivity
A full-length STIV clone was successfully constructed by PCR
ampliﬁcation of three overlapping segments of the native STIV
genome and insertion into the E. coli pCRII-TOPO-TA plasmid. An
EcoRI digest of the full-length clone produced the expected banding
pattern (Fig. 2A) and DNA sequencing of selected regions of the
cloned viral DNA conﬁrmed that the cloned DNA was identical to the
native STIV genome. The only exceptionwas the introduction of a new
BamHI restriction endonuclease site to facilitate the removal of the
pCRII-TOPO-TA vector sequence prior to transfection. The creation of
this BamHI site did not result in any altered protein coding capacity
within the viral genome.
Transfection of the full-length clone into S. solfataricus resulted in
the production of both progeny viral particles (Fig. 2B) and genomes
(Fig. 2C). Puriﬁcation of virus from the primary transformed cultures
and passage of this virus into early log S. solfataricus cells
demonstrated that the cloned virus was infectious and produced
plaques similar to native virus. Transfection of DNA without prior
removal of the E. coli vector was not successful. However, the presence
of 106 bp of vector sequence in the non-coding region of the STIV
genome did not affect infectivity. This indicates that the presence of
the entire 3.9 kb of pCRII-TOPO-TA vector sequence prevents viral
replication. Likewise, transfection with linear BamHI digested STIV
genome was non-infectious. Transformation of the circular cloned
viral DNA resulted in an infection cycle that was delayed by 20 hours
as compared to native STIV infection, but eventually reached the same
magnitude as infection with native virus as estimated by qPCR
(Fig. 2C). However, subsequent infection with virus particles obtained
from a transfected culture produced a similar timing as native virus.Due to the low plating efﬁciency a pfu/μg value for transformation
efﬁciency was not determined. Instead, a qPCR assay was used to
estimate the number of new viral genomes per mL of media per μg of
transformed DNA (Table S2). Transformation efﬁciency of S. solfatar-
icus strain 2-2-12 with the cloned STIV DNA was approximately 400
fold reduced as compared to infection with puriﬁed virus (1.5×1011
genomes/mL per produced per 1 μg DNA (1.8×1010 genomes) vs.
5.7×1011 genomes/mL produced per 4.8×108 genomes of virus used
as inoculum). In an attempt to assess the host range of STIV, various
hosts were tested for infection with native virus and transfection with
the cloned STIV DNA. The pattern of successful transfection closely
followed the pattern of host competency for infectionwith native STIV
(Table S2). Only S. solfataricus supported viral replication.
STIV infectious clone allows for targeted gene alterations
Selected STIV gene disruptions and point mutations were
performed to demonstrate the ability of the STIV full-length clone to
serve as the basis for a viral genetic system. STIV ORFs A197, B116,
B345, and C381 were chosen for gene modiﬁcation experiments.
Disruption of A197, B345, and C381 were lethal to virus replication,
with no new viral genomes detected by qPCR. In contrast, transfection
with cloned viral DNA harboring a B116 frame shift mutation and a
single conserved amino acid substitution within A197 produced
infectious virus. These cell cultures were both positive by qPCR for the
MCP gene and produced virus particles. The virus isolated from the
supernatant of these cultures was infectious when introduced into
fresh S. solfataricus cells (Fig. 3A). Maintenance of the B116 frame-
shift site through multiple passages was conﬁrmed by DNA sequenc-
ing. A comparison between the wild type and B116 frame-shift virus
infections showed that the B116 frame-shift produced a delayed
infection cycle of 24 hours as compared to wild type, but eventually
reached similar levels (Fig. 3A). Western blot analysis with B116
antibodies did not detect any B116 protein in the B116 frame-shift
transformed cells (Fig. 3B); however, this may reﬂect our detection
limits rather than a true absence of the B116 protein, as genome
replication was at a lower level in those samples as compared to wild
type. Plaque assay analysis showed that the virus still lysed its host
cells, but manifested as a small plaque phenotype. The average plaque
size produced by the B116 frame-shift mutant was reduced by ~90%
as compared to wild type virus (Fig. 4A, B, C).
Discussion
Construction of an infectious clone of STIV provides a valuable
resource for the genetic analysis of this virus and for probing its
interaction with its Sulfolobus host. The observation that the cloned
Fig. 2. Analysis of full-length STIV clone and transfection in S. solfataricus. A. Lane 1. Ladder. Lane 2. EcoRI digest of the full-length STIV clone in the pCRII-TOPO-TA vector. B. TEMs of
viral progeny from transfected cultures. C. Averages and standard deviation of time course comparison of STIV transfection vs. a natural infection cycle as measured by qPCR.
8 J.F. Wirth et al. / Virology 415 (2011) 6–11viral DNA is infectious demonstrates that the viral or host proteins
associated with the virion are not strictly required for infection. The
demonstration that the cloned viral DNA can be used as a template for
targeted gene disruption and point mutations of STIV ORFs shouldFig. 3. Analysis of ΔB116 infection in S. solfataricus. A. Averages and standard deviation
of time course of ΔB116 vs. wild type (WT) infection as measured by qPCR. B. Western
blot ofΔB116 andWT infected cells: Lanes 1–3 puriﬁed B116 protein loading controls of
1 μg, 100 ng, 10 ng, respectively. 4. WT t=24, 5. WT t=48, 6. ΔB116 t=24, 7. ΔB116
t=48, 8. Uninfected S. solfataricus strain 2-2-12.greatly facilitate detailed genetic and biochemical analysis of this
virus. The full-length STIV cloned genome also provides the
foundation for exploring the use of STIV as a vector for gene delivery
and as a heterologous protein expression system for Sulfolobus. This is
only the second crenarchaeal virus for which an infectious clone has
been produced.
STIV was originally isolated from an uncharacterized Sulfolobus sp.
from Yellowstone National Park. It was subsequently demonstrated toFig. 4. Analysis of ΔB116 STIV plaques. A. Small plaque phenotype of ΔB116 STIV
(arrows). B. Normal plaques of WT STIV. C. PCR from plaques of ΔB116 virus: 1,3.
plaque, 2,4. lawn.
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S. solfataricus strain 2-2-12 (a highly susceptible strain derived from
S. solfataricus P2) (Ortmann et al., 2008) and S. solfataricus P1 (a
second Italian isolate) (Rice et al., 2004). However, STIV has not
successfully replicated in any other Sulfolobus species or strains tested
to date, including several Yellowstone isolates. Our attempts to use
transfection with the cloned STIV DNA failed to produce viral
infections except in S. solfataricus isolates. The inability to overcome
the host range of STIV by transfection of cloned DNA is in contrast to
examples from other archaeal viruses. SH1 and His2 are viruses that
infect Haloarchaeal hosts (euryarchaeotes). His2 only infects one host,
Haloarcula hispanica, while SH1 infects H. hispanica and one
uncharacterized Halorubrum species. However transfection was
successful in six of twelve other hosts tested, spanning four genera
(Porter and Dyall-Smith, 2008; Porter et al., 2005; Porter et al., 2008).
Of particular interest is the inability to transfect or infect isolates from
Yellowstone National Park, which presumably would be more closely
related to the isolate from which STIV was obtained than the lab
strains S. solfataricus P2 and P1 originally isolated from Italy. The
inability to transfect any of these isolates suggests that there is an
inherent biochemical inability to support viral replication rather than
simply a lack of a cell-surface receptor, corroborating previous
microarray results in which no obvious membrane proteins were
differentially regulated when comparing S. solfataricus strain 2-2-12
to resistant strains of S. solfataricus P2 (Ortmann et al., 2008).
The inability to observe infection when the transfected DNA either
contains large amounts of foreign sequences (e.g. the plasmid vector) or
is a linear molecule is not surprising. For many viruses, there is only a
limited ability to accommodate extra DNA within the virion. The
requirement of removing the pCRII-TOPO-TA vector appears to be a size
limitation rather than inability to tolerate an insertion into theparticular
site that was chosen. A construct was made in which a small fragment
(106 bp) of the pCRII-TOPO-TA vector was left in the STIV genome. This
construct successfully replicated in S. solfataricus, producing viable virus
particles. The requirement for a circular genome indicated that viral
DNA replicationeither reliesuponacircularDNAreplicationmechanism
or a circular template for transcription.
The possible phenotypic outcomes of targeted viral gene modiﬁ-
cations are either no change from the wild type phenotype, lethality
or an altered phenotype. Our B345, B116 and A197 gene disruption
and point mutations experiments were guided by structural infor-
mation. A197 is a putative glycosyltransferase, B345 is the major
capsid protein, and B116 is a putative DNA binding protein. Creating
frame shift mutations which results in the introduction of premature
stop codons within the A197 and C381, and introduced a serine
residue into B345 was non-infectious, indicating that these genes are
essential. The point at which the defect interferes with the viral life
cycle is as yet undeﬁned. It is not surprising that eliminating
glycosyltransferase function would eliminate infectivity. The MCP of
STIV is gycosylated (Maaty et al., 2006) and it is suspected that the
A197 gene product may be responsible. Eliminating MCP glycosyla-
tionmay prevent assembly and or release of virus from cells. It is more
surprising that a single serine residue addition to the MCP eliminates
infectivity. Based on the crystal structure and cryo-EM image
reconstruction of STIV, the added serine residue lies within a short
surface exposed loop region of the MCP and would seem unlikely to
signiﬁcantly disrupt MCP function. The fact that this mutation is lethal
suggests that this region may be interacting with a critical ligand
required for infection. ORF C381 codes for a structural protein that is
believed to be a part of the turret appendages found at each of the
ﬁve-fold axis of the virion. Homologymodeling suggests it may have a
cadherin-like fold which would suggest it might play a role in cell-
surface adhesion (Khayat et al., 2010). The disruption of C381 could
interfere viral entry as well as viral assembly. Further genetic analysis
will be required to determine the point of defect in the viral
replication cycle.The crystal structure of the B116 protein indicates that it is a highly
conserved DNA binding protein that is found in a wide diversity of
crenarchaeal viruses (Larson et al., 2007b). The ability to knock it out
and maintain a viable virus demonstrates that it is a non-essential
gene. However, the altered phenotype of small plaques and delayed
infection cycle indicates that the null mutant is a crippled as
compared to wild type. While the structure and sequence comparison
to proteins of other crenarchaeal viruses suggests that B116 is a DNA
binding protein (Larson et al., 2007b), its DNA target has not yet been
demonstrated. Gel-shift experiments with fragmented STIV genomic
DNA have not yielded any binding sites. No change in viral
transcription patterns other than timing for this mutant suggests
that B116 is not a regulator of STIV transcription and may be involved
with modulating host transcription.
The construction of a full-length infectious clone for STIV provides
a valuable genetic tool for investigation of the STIV replication cycle
and its interactions with its host. With both viral and host genetic
tools now in hand, it should be possible to gain a greater
understanding into the archaeal lifestyle and in particular adaptations
required for life at high temperatures.
Materials and methods
Construction of an STIV full-length clone
The 21 kb full-length STIV clone was constructed by sequential
addition of PCR products to the pCRII-TOPO-TA Escherichia coli cloning
vector (Invitrogen). Brieﬂy outlined, native viral DNA isolated from
puriﬁed STIV virions was used as the template for all PCR reactions.
The 17.7 kb genome of STIV was PCR ampliﬁed using iProof high
ﬁdelity DNA polymerase (Bio-Rad) in three separate overlapping
segments (7436 bp, 4488 bp and 5849 bp segments) using oligonu-
cleotide primers that either spanned unique restriction endonuclease
sites, or in the case of 1F and 1R, created a single base change that
engineered a new unique BamHI site (Table S1). Each PCR productwas
cloned into the pCRII-TOPO-TA plasmid per manufacturer's protocol.
The full-length genome of STIV was constructed within the pCRII-
TOPO-TA plasmid by sequential addition of the three viral PCR
products. This was accomplished by ﬁrst cloning the 4488 bp STIV
genome segment from position 14586–1410 (through STIV position
0) into the pCRII-TOPO-TA plasmid to produce an 8461 bp clone. This
8461 bp clone was used as the destination plasmid for the addition of
all subsequent STIV PCR products. To accomplish this, the 8461 bp
clone was digested with NcoI and BstXI (Promega) to remove a 51 bp
fragment from the plasmid polylinker region to the NcoI site in the
STIV genome sequence. A 11,408 bp STIV clone, encompassing the
STIV genome from positions 7188–14623, was digested with BxtXI
and NcoI and ligated into BxtXI and NcoI linearized 8461 bp clone
using T4 DNA ligase (Promega) producing a 15,802 bp intermediate
clone. In the ﬁnal assembly step, a 9821 bp STIV clone encompassing
positions 1376–7224 was digested with NotI (Promega) and AvrII
(New England Biolabs) and ligated into NotI and AvrII digested
15,802 bp intermediate clone. The ﬁnal construct was a 21,582 bp
clone (17,697 bp of STIV genome with complementary terminal
repeated sequences and 3885 bp of plasmid vector) and designated
pFLSTIV (Fig. 1). E. coli (DH10B XL2 Blue, Stratagene) harboring
pFLSTIV was grown and plasmid DNA puriﬁed by standard protocols
(Sambrook et al., 1989). The ﬁnal construct was conﬁrmed by
restriction endonuclease digest mapping and by selected DNA
sequencing.
Construction of STIV gene disruption mutants
Different strategies were employed to construct both gene
disruptions and gene modiﬁcations within the STIV genome. Frame-
shift mutations were introduced into STIV genes B116, A197, and
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acid additions and substitution mutations were introduced into B345
and A197.
The frame-shift mutations in B116, A197, and the single amino
acid insert in B345 were performed by selected restriction endonu-
clease digestion of pFLSTIV, followed by end repair with Klenow
fragment (Promega) to introduce a frame shift or insert within each
targeted ORF. To create a B116 frameshift mutation, pFLSTIV was
digested with PacI. After the end repair reaction, two base pairs were
added creating a frameshift at position 85 and introducing a stop
codon at position 88. The presence of the frameshift was conﬁrmed in
the progeny viral particles by DNA sequencing. To create an A197
frameshift mutation, pFLSTIV was digested with SacII and end
repaired. This resulted in the insertion of two nucleotides, creating a
frameshift at residue 179 and the introduction of a stop codon at
position 183. An amino acid insertion into B345 was created by
digestion of pFLSTIV with Bsu361 followed by end repair, inserting
three nucleotides, resulting in the insertion of a single serine residue
at position 223. Each end repair reactionwas subsequently ligated and
transformed into E. coli. Colonies were screened by PCR using primers
ﬂanking the region of interest spanning the ﬁlled restriction
endonuclease site (Table S1). Constructs were digested with the
appropriate restriction endonuclease to conﬁrm the loss of the
targeted restriction endonuclease site and were conﬁrmed by DNA
sequencing with primers A197 SacII screen F and R, B116 PacI screen F
and R, or B345 5′F and B345 mid R (Table S1).
Point mutations were introduced into A197 and C381 by site
directedmutagenesis using theQuickChange kit (Stratagene). For A197,
a 3842 bp fragment was ampliﬁed from the WT clone using iProof
polymerase (Bio-Rad) and cloned into the pSMART HCKan vector
(Lucigen). This fragment encompassed the A197 gene and two unique
restriction sites, XmaI and SacII (Promega). Three pointmutation clones
were created: D151E, D151N, and D151H. The XmaI and SacII sites were
subsequently used to excise the mutated A197 gene from the subclone
and ligate it into the full-length clone. All mutations were conﬁrmed by
sequencing with the A197 R seq primer (Table S1). For C381, a 4007 bp
fragmentwas ampliﬁed from theWTclone using iProof polymerase and
cloned into the pCRII-TOPO-TA vector (Invitrogen). This fragment
included the C381 gene and the unique restriction sites, SacII (Promega)
and PacI (New England Biolabs). One mutant was the result of a point
mutation that changed lysine 158 into a stop codon and the other
mutationwas a single basepair deletion at base pair 105,which resulted
in a frameshift. The two unique restriction sites were used to ligate the
mutated piece back into the full-length viral genome. Mutations were
veriﬁed by DNA sequencing with primers C381 331F and C381 602R or
C381 331R and C381 602R (Table S1).
The deletion mutant of B345 was created by deleting the C-terminal
22 amino acids which had been hypothesized to interact with the
internal lipid layer (Maaty et al., 2006). A B345 ‘sub-clone’ was created
by amplifying the B345 and C557 genes from the STIV genome. This
4488 bp fragment was cloned into the pCRII-TOPO-TA vector following
manufacturer's guidelines. In order to delete 66 bps from the C-terminal
end of B345, inverted primers were designed that would engineer a
unique AgeI site in the place of the 22 amino acids. After ampliﬁcation,
the product was digested with AgeI (Promega) and ligated to
recircularize the plasmid. The mutant was screened for the presence
of the AgeI site and sequenced with primers B345-AgeI seq-F and R
(Table S1). The B345 C-terminal deletion mutant was ligated back into
the STIV full-length genome using the unique restriction sites Bsu36I
and BsiWI (New England Biolabs).
A deletion mutant of A197 was constructed by removing 569
nucleotides of the gene, leaving 5 nucleotides at the 5′ end and 15
nucleotides at the 3′ end. An A197 ‘sub-clone’ was constructed by
amplifying the region of STIV encompassing the A197 gene and
spanning XmaI and AvrII unique restriction sites using the A197 XmaI
F and A197 AvrII R primers. The resulting product was cloned into thepCRII-TOPO-TA vector to produce a 9085 bp clone. The deletion of the
A197 gene was then constructed by inverted PCR using primers A197
KO AgeI F and A197 KO AgeI R which added an AgeI site at the ends of
the amplicon. The PCR product was then digested with AgeI and
ligated together resulting in a circular plasmid with 569 bps of the
A197 gene deleted. This product was then transformed into XL2 Blue
E. coli cells (Stratagene) and correct colonies were screened for the
presence of the AgeI site and further conﬁrmed by DNA sequencing
with primers A197 AgeI screen F and R (Table S1).
Preparation of cloned viral DNA for transformation into S. solfataricus
Puriﬁed wild type (WT) pFLSTIV, gene disruption and point
mutation clones were digested with BamHI (Promega) restriction
endonuclease, followed by ligation with T4 DNA ligase to remove the
pCRII-TOPO-TA vector. This resulted in circular STIV genomes similar
to the native genome with the exception of a single base change,
which introduces a unique BamHI site without altering the amino acid
coding. To examine the effects of maintaining small amounts of
heterologous DNA sequences on infectivity, one WT construct was
also prepared leaving a 106 bp fragment of the pCRII-TOPO-TA vector
in the STIV chromosome. This was constructed by digestion with SacI
and ApaI (Promega); ends were repaired with Klenow fragment and
ligated. This construct was conﬁrmed by sequencing with primers
STIV 886F and 1885R.
Transfection of S. solfataricus with viral DNA
Transformation of S. solfataricus strain 2-2-12 (Ortmann et al.,
2008) was performed using a protocol adapted from Elferink et al.
(1996), Schleper et al. (1992) and Albers et al. (2005). S. solfataricus
cultures were grown overnight to an OD650~0.2. Cells were cooled on
ice and collected by centrifugation at 5000g for 5 min. The cell pellet
was washed three times with cold 20 mM sucrose, each time reducing
the total volume (50 mL, 25 mL, 1 mL). The ﬁnal cell pellet was
resuspended in sucrose at ~1010 cells mL−1 (500 mL of OD650~0.2
culture is reduced to 500 μL). Approximately 500 ng of DNA was used
for each transformation. Electroporations were performed using the
Bio-Rad Gene Pulser Xcell at 1500 V, 25 μF, and 400 ohm for a time
constant of 9 ms (1 mm gap cuvette). Electroporated cells weremixed
with 1 mL ice cold ddH2O and incubated on ice for 10 min, transferred
to 80 °C for 10 min and ﬁnally into 25 mL prewarmedmedium 182 pH
2.5 (DSMZ), and cultures were incubated at 80 °C. Control trans-
fections included native STIV DNA isolated directly from puriﬁed virus
and mock transfections. In addition to S. solfataricus, Sulfolobus
tokodaii (JCM 10545; Japan Collection of Microorganisms) (Suzuki
et al., 2002), Sulfolobus islandicus (Y.G.57.14 and Y.N.15.51) (Held and
Whitaker, 2009), Sulfolobus acidocaldarius (DSM639) (Chen et al.,
2005), and Sulfolobus sp. strain 2025 (Schelert et al., 2004;
Worthington et al., 2003) were transfected using the above protocol
and assayed for STIV production as described below. All transfections
were performed in triplicate and negative results were further
conﬁrmed by independent replicates of the entire experiment.
Detection of infectious progeny virus following transfection with cloned
viral DNA
Transfected S. solfataricus cultures were monitored for up to
72 hours post transfection by absorbance at OD650 for cell growth and
by quantitative PCR (qPCR) for production of viral genomes using PCR
primers to the major capsid protein (Ortmann et al., 2008). Cultures
that were positive by qPCR were screened by transmission electron
microscopy (TEM, Leo 912AB) for presence of virus particles. Western
blot analysis with polyclonal antibodies to the STIV major capsid
protein (MCP ORF B345) was used to conﬁrm the presence of virus.
Western blot analysis using polyclonal antibodies to STIV B116 and
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and C381 gene products.
The presence of infectious virus resulting from transfection with the
cloned STIV DNA was assayed by both passage of virus to new cell
cultures and by plaque assays. Transfected cell cultures were harvested
at 40 hours post transfection and prepared for virus passage by
centrifugation at 5000g for 5 min, the supernatant was ﬁltered through
0.8/0.2 μm ﬁlters (Pall Acrodisc 25 mm PF Syringe Filter), and
concentrated ~10 fold by ﬁltration through a 100 kDa MWCO ﬁlter
(Amicon Millipore). The concentrated supernatant was used as source
of inoculum. Infections using cell-free concentrated transfection
supernatants were performed by addition of~3×109 VLPs to early log
(OD650 ~0.2) S. solfataricus cells inmedium182 at pH2.5 and incubation
at 80 °C. Cell cultures were subsequently analyzed by qPCR and TEM for
presenceof virus genomes andvirus particles asdescribed above. Plaque
assays were performed as previously described (Brumﬁeld et al., 2009).
Brieﬂy, dilutions of cell free supernatants of cultures transfected with
cloned viral DNA were incubated with 500 μL early log S. solfataricus
cells at OD650 ~0.2 for 15 min at 80 °C. Medium 182 with 0.2% w/v
Phytagel (Sigma) at pH 2.5 and 80 °C was added to the culture and
immediately spread onto medium 182 (1% w/v Phytagel) pH 2.5 plates
and incubated at 80 °C. Plaque phenotypes were visually scored and
plaques were tested for virus production by PCR for the STIV MCP. PCR
was performed by pickingmaterial from the edge of a plaque into a PCR
reaction and was compared material from the lawn.
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